Clinical Trials for Metastatic Renal Cell Carcinoma

Find clinical trials for metastatic renal cell carcinoma. Discover research opportunities and treatment options in your area.

31 Active Trials Found

Showing 31 trials on this page

Page 2 of 2

NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy

NCT ID: NCT03589339

The clinical trial titled "NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy" is exploring a new treatment approach for patients with advanced ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Tampa, Florida, United States +14 more

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

NCT ID: NCT05263050

This clinical trial is studying a new way to give cabozantinib, a medication used to treat certain types of cancer, specifically metastatic renal cell carcinoma (a type of kidney cancer that has sp...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

NCT ID: NCT05863351

The SOAR Study is a clinical trial that is looking at two different treatments for patients with kidney cancer that has spread to a few other places in the body, a condition known as metastatic ren...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Buffalo, New York, United States +115 more

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

NCT ID: NCT04510597

The PROBE Trial is a study that aims to find out whether adding surgery to a combination of immunotherapy drugs is more effective than just using immunotherapy alone for patients with metastatic ki...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Cleveland, Ohio, United States +398 more

Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib

NCT ID: NCT06548867

This clinical trial, called CABOGEN, is looking at how well a medication called cabozantinib works for patients with metastatic clear cell renal cell carcinoma (mccRCC), which is a type of kidney c...

Recruiting

Type: observational Locations: Reggio Emilia, , Italy

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

NCT ID: NCT05269381

This clinical trial is investigating a new type of personalized vaccine designed to help the immune system recognize and attack advanced solid tumors, which are cancers that have spread beyond thei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

NCT ID: NCT06399419

This clinical trial is testing a new treatment approach for patients with advanced kidney cancer, specifically a type called renal cell carcinoma that may have spread to other parts of the body. Th...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)

NCT ID: NCT05259319

This clinical trial, called IMMUNOs-SBRT, is looking at a new treatment approach for patients with certain types of cancer that have spread to other parts of the body, specifically metastatic non-s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Dijon, Bourgogne, France

Drug Screening Using Novel IMD in Renal Cell Carcinoma

NCT ID: NCT05700461

This clinical trial is studying a new way to test the effectiveness of cancer drugs for patients with metastatic renal cell carcinoma (a type of kidney cancer that has spread to other parts of the ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

NCT ID: NCT05817903

This clinical trial is studying the effects of adding a drug called axitinib to nivolumab, compared to continuing with nivolumab alone, for patients with metastatic renal cell carcinoma (mRCC) who ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Padova, , Italy, Parma, , Italy +21 more

Urine Omics Predicting IO Therapy Responses in mRCC Patients

NCT ID: NCT04712305

This clinical trial, called "Urine Omics Predicting IO Therapy Responses in mRCC Patients," is studying how certain substances found in urine can help predict how well patients with advanced kidney...

Recruiting

Type: observational Locations: Taipei, , Taiwan

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions